ChemicalBook >> CAS DataBase List >>Enfortumab Vedotin

Enfortumab Vedotin

CAS No.
1346452-25-2
Chemical Name:
Enfortumab Vedotin
Synonyms
Enfortumab;Enfortumab Vedotin;Research Grade Enfortumab;Research Grade Enfortumab(DHJ41001);Enfortumab vedotin-ejfv (anti-Nectin-4)
CBNumber:
CB58080892
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-08-11 13:38:40

Enfortumab Vedotin Properties

form Liquid
color Colorless to light yellow
FDA UNII DLE8519RWM
ATC code L01XC36

Enfortumab Vedotin price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth CLA1341 Enfortumab 1346452-25-2 1mg $1306.25 2026-06-04 Buy
Biosynth CLA1341 Enfortumab 1346452-25-2 5mg $2646.9 2026-06-04 Buy
Biosynth CLA1341 Enfortumab 1346452-25-2 10mg $3946.3 2026-06-04 Buy
Biosynth CLA1341 Enfortumab 1346452-25-2 50mg $7425 2026-06-04 Buy
Biosynth CLA1341 Enfortumab 1346452-25-2 100mg $9625 2026-06-04 Buy
Product number Packaging Price Buy
CLA1341 1mg $1306.25 Buy
CLA1341 5mg $2646.9 Buy
CLA1341 10mg $3946.3 Buy
CLA1341 50mg $7425 Buy
CLA1341 100mg $9625 Buy

Enfortumab Vedotin Chemical Properties,Uses,Production

Uses

Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate. Enfortumab vedotin-ejfv is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE (HY-15162) via a protease-cleavable maleimidocaproylvaline-citrulline linker (SGD-1006). Nectin-4 is an adhesion protein involved in cellular processes and tumorigenesis, and Enfortumab vedotin-ejfv is indicated for the inhibition of locally advanced or metastatic urothelial carcinoma[1][2].

Synthesis

Synthesis of enfortumab vedotin
Enfortumab Vedotin synthesis

References

[1] Halford Z, et al. Enfortumab Vedotin-ejfv: A First-in-Class Anti-Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma. Ann Pharmacother. 2021 Jun;55(6):772-782. DOI:10.1177/1060028020960402
[2] Chang E, et al. FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma. Clin Cancer Res. 2021 Feb 15;27(4):922-927. DOI:10.1158/1078-0432.CCR-20-2275

Enfortumab Vedotin Preparation Products And Raw materials

Raw materials

Preparation Products

Enfortumab Vedotin Suppliers

Global( 18)Suppliers
Supplier Tel Email Country ProdList Advantage
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
BOC Sciences 16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Changsha Fuzhen Biotechnology Co.,LTD 15111215862 18229892877 3062105966@qq.com China 5550 58
Atagenix Laboratories 027-87008169 17762441161 info@atagenix.com China 9997 58
Shanghai Amole Biotechnology Co., Ltd. 13370042665 18916960931 2596183085@qq.com China 17234 58

Related articles

View Lastest Price from Enfortumab Vedotin manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Enfortumab vedotin-ejfv pictures 2026-08-11 Enfortumab vedotin-ejfv
1346452-25-2
$773.00-3120.00 95.00% 10g TargetMol Chemicals Inc.
Enfortumab Vedotin Research Grade Enfortumab(DHJ41001) Research Grade Enfortumab Enfortumab vedotin-ejfv (anti-Nectin-4) Enfortumab 1346452-25-2